Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trialRona M Smith, Rachel B Jones, Ulrich Specks, Simon Bond, Marianna Nodale, Reem Al-jayyousi, Jacqueline Andrews, Annette Bruchfeld, Brian Camilleri, Simon Carette, Chee Kay Cheung, Vimal Derebail, Tim Doulton, Alastair Ferraro, Lindsy ForbessSee the full list of authors
23 March 2023
The provisional OMERACT ultrasonography score for giant cell arteritisChristian Dejaco, Cristina Ponte, Sara Monti, Davide Rozza, Carlo Alberto Scirè, Lene Terslev, George A W Bruyn, Dennis Boumans, Wolfgang Hartung, Alojzija Hočevar, Marcin Milchert, Uffe Møller Døhn, Chetan B Mukhtyar, Markus Aschwanden, Philipp BoschSee the full list of authors
10 March 2023
Proteinase 3 promotes formation of multinucleated giant cells and granuloma-like structures in patients with granulomatosis with polyangiitisScott R Henderson, Harry Horsley, Paul Frankel, Maryam Khosravi, Talya Goble, Stephen Carter, Marilina Antonelou, Rhys D R Evans, Xiang Zhang, Tai-Ying Chu, Hsi-Hsien Lin, Siamon Gordon, Alan David Salama
17 February 2023
Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposingLourdes Ortiz-Fernández, Elio G Carmona, Martin Kerick, Paul Lyons, Francisco David Carmona, Raquel López Mejías, Chiea Chuen Khor, Peter C Grayson, Enrico Tombetti, Lindi Jiang, Haner Direskeneli, Guher Saruhan-Direskeneli, José-Luis Callejas-Rubio, Augusto Vaglio, Carlo SalvaraniSee the full list of authors
16 February 2023
Risk factors for serious infections in ANCA-associated vasculitisBalazs Odler, Regina Riedl, Philipp Gauckler, Jae Il Shin, Johannes Leierer, Peter A Merkel, William St. Clair, Fernando Fervenza, Duvuru Geetha, Paul Monach, David Jayne, Rona M Smith, Alexander Rosenkranz, Ulrich Specks, John H StoneSee the full list of authors
26 January 2023
The effect of achieving serological remission on subsequent risk of relapse, end-stage renal disease and mortality in ANCA-associated vasculitis: a target trial emulation studyGregory McDermott, Xiaoqing Fu, Claire Cook, Catherine Ahola, Brett Doliner, Jennifer Hanberg, John H Stone, Hyon K Choi, Yuqing Zhang, Zachary S Wallace
12 September 2022
Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remissionGabriele Gamerith, Finn Mildner, Peter A Merkel, Kristina Harris, Laura Cooney, Noha Lim, Robert Spiera, Philip Seo, Carol A Langford, Gary S Hoffman, E William St Clair, Fernando C Fervenza, Paul Monach, Steven R Ytterberg, Duvuru GeethaSee the full list of authors
23 January 2023
Methylome and transcriptome profiling of giant cell arteritis monocytes reveals novel pathways involved in disease pathogenesis and molecular response to glucocorticoidsElkyn Estupiñán-Moreno, Lourdes Ortiz-Fernández, Tianlu Li, Jose Hernández-Rodríguez, Laura Ciudad, Eduardo Andrés-León, Laura Carmen Terron-Camero, Sergio Prieto-González, Georgina Espígol-Frigolé, Maria Cinta Cid, Ana Márquez, Esteban Ballestar, Javier Martín
11 August 2022
CSF2-dependent monocyte education in the pathogenesis of ANCA-induced glomerulonephritisAnthony Rousselle, Janis Sonnemann, Kerstin Amann, Alexander Mildner, Dörte Lodka, Lovis Kling, Markus Bieringer, Udo Schneider, Achim Leutz, Philipp Enghard, Ralph Kettritz, Adrian Schreiber
12 July 2022
Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot studyMatthew J Koster, Cynthia S Crowson, Rachel E Giblon, Jane M Jaquith, Ali Duarte-García, Eric L Matteson, Cornelia M Weyand, Kenneth J Warrington
16 May 2022
